Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122721704 | 12272170 | 4 | F | 2014 | 20160831 | 20160415 | 20160914 | EXP | US-ACORDA-ACO_123101_2016 | ACORDA | 0.00 | F | Y | 77.98000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122721704 | 12272170 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 122721704 | 12272170 | 2 | C | TRULICITY | DULAGLUTIDE | 1 | Parenteral | 0.75MG/0.5ML | U | 0 | /wk | ||||||||
| 122721704 | 12272170 | 3 | C | SUCRALFATE. | SUCRALFATE | 1 | Oral | 1 G, BID | U | 0 | 1 | G | BID | ||||||
| 122721704 | 12272170 | 4 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | |||||||
| 122721704 | 12272170 | 5 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 1/2 TABLET, QD | U | 0 | QD | ||||||||
| 122721704 | 12272170 | 6 | C | Fish oil + D3 | 2 | Oral | 1 TABLET DAILY | U | 0 | ||||||||||
| 122721704 | 12272170 | 7 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 122721704 | 12272170 | 8 | C | NUVIGIL | ARMODAFINIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 122721704 | 12272170 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 100 ?G, QD | U | 0 | 100 | UG | QD | ||||||
| 122721704 | 12272170 | 10 | C | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 240MG, BID | U | 0 | |||||||||
| 122721704 | 12272170 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Parenteral | 1000MCG/1ML, MONTHLY | U | 0 | /month | ||||||||
| 122721704 | 12272170 | 12 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 400 ?G, QD | U | 0 | 400 | UG | QD | ||||||
| 122721704 | 12272170 | 13 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 10-325 MG, UP TO 4 TABLETS DAILY | U | 0 | |||||||||
| 122721704 | 12272170 | 14 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | QD | ||||||
| 122721704 | 12272170 | 15 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 122721704 | 12272170 | 16 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 122721704 | 12272170 | 17 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TID | ||||||
| 122721704 | 12272170 | 18 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 122721704 | 12272170 | 19 | C | CRANBERRY. | CRANBERRY | 1 | Oral | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 122721704 | 12272170 | 20 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 5000 IU, WEEKLY | U | 0 | 5000 | IU | /wk | ||||||
| 122721704 | 12272170 | 21 | C | PROVIGIL | MODAFINIL | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 122721704 | 12272170 | 22 | C | CONSTULOSE | LACTULOSE | 1 | Oral | 10GM/15ML ONE TABLET, DAILY | U | 0 | QD | ||||||||
| 122721704 | 12272170 | 23 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 25 MG, QID | U | 0 | 25 | MG | QID | ||||||
| 122721704 | 12272170 | 24 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | |||||||
| 122721704 | 12272170 | 25 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 122721704 | 12272170 | 26 | C | LIDOCAINE. | LIDOCAINE | 1 | Unknown | APPLY TO AFFECTED AREA ONCE TO TWICE A DAY | U | 0 | |||||||||
| 122721704 | 12272170 | 27 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 13 HOURS, 7 HOURS AND 1 HOUR PRIOR TO MRI | U | 0 | 50 | MG | |||||||
| 122721704 | 12272170 | 28 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 25 MG, 1 HOUR PRIOR TO MRI | U | 0 | 25 | MG | |||||||
| 122721704 | 12272170 | 29 | C | Magnesium | MAGNESIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122721704 | 12272170 | 1 | Multiple sclerosis |
| 122721704 | 12272170 | 2 | Product used for unknown indication |
| 122721704 | 12272170 | 3 | Product used for unknown indication |
| 122721704 | 12272170 | 4 | Product used for unknown indication |
| 122721704 | 12272170 | 5 | Product used for unknown indication |
| 122721704 | 12272170 | 6 | Product used for unknown indication |
| 122721704 | 12272170 | 7 | Product used for unknown indication |
| 122721704 | 12272170 | 8 | Product used for unknown indication |
| 122721704 | 12272170 | 9 | Product used for unknown indication |
| 122721704 | 12272170 | 10 | Product used for unknown indication |
| 122721704 | 12272170 | 11 | Product used for unknown indication |
| 122721704 | 12272170 | 12 | Product used for unknown indication |
| 122721704 | 12272170 | 13 | Product used for unknown indication |
| 122721704 | 12272170 | 14 | Product used for unknown indication |
| 122721704 | 12272170 | 15 | Product used for unknown indication |
| 122721704 | 12272170 | 16 | Product used for unknown indication |
| 122721704 | 12272170 | 17 | Product used for unknown indication |
| 122721704 | 12272170 | 18 | Product used for unknown indication |
| 122721704 | 12272170 | 19 | Product used for unknown indication |
| 122721704 | 12272170 | 20 | Product used for unknown indication |
| 122721704 | 12272170 | 21 | Product used for unknown indication |
| 122721704 | 12272170 | 22 | Product used for unknown indication |
| 122721704 | 12272170 | 23 | Product used for unknown indication |
| 122721704 | 12272170 | 24 | Product used for unknown indication |
| 122721704 | 12272170 | 25 | Product used for unknown indication |
| 122721704 | 12272170 | 26 | Product used for unknown indication |
| 122721704 | 12272170 | 27 | Product used for unknown indication |
| 122721704 | 12272170 | 28 | Product used for unknown indication |
| 122721704 | 12272170 | 29 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122721704 | 12272170 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122721704 | 12272170 | Cold sweat | |
| 122721704 | 12272170 | Flushing | |
| 122721704 | 12272170 | Kidney infection | |
| 122721704 | 12272170 | Nasopharyngitis | |
| 122721704 | 12272170 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122721704 | 12272170 | 4 | 20151104 | 0 | ||
| 122721704 | 12272170 | 10 | 20141217 | 0 | ||
| 122721704 | 12272170 | 20 | 20150930 | 0 | ||
| 122721704 | 12272170 | 21 | 20151104 | 0 | ||
| 122721704 | 12272170 | 26 | 20160502 | 0 |